GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹72 Cr | ₹45 Cr | ₹40 Cr | ₹30 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹72 Cr |
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹24 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹72 Cr | 62.49 | |
| Mar2025 | ₹45 Cr | 10.54 | |
| Mar2024 | ₹40 Cr | 36.57 | |
| Mar2023 | ₹30 Cr | 21.91 | |
| Mar2022 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹194.8 Cr | -6.6% | -20.4% | -38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -6.6% |
-20.4% |
-38.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses